PROPHET – Event on Personalised Prevention

PROPHET – Event on Personalised Prevention

Joint Event with 4PCAN Initiative
March 26–27, 2026
Rome, Italy
Register for the Event

About the Event

We are pleased to invite you to a joint event on personalised prevention that will take place in Rome on 26–27 March 2026. Online participation will also be possible.

This event is co-organised by PROPHET together with another EU initiative, 4PCAN. During the event, we will present the PROPHET Strategic Research and Innovation Agenda (SRIA) and the related Roadmap, and foster dialogue among several EU-funded initiatives active in the field of personalised prevention, including PROPHET, 4PCAN, EuCanScreen, PreventNCD, JANE2, EUNetCCC, JA PCM, THCS, and the EPPerMed partnership

Important Information

Participants wishing to attend the event in person will be expected to cover their own travel and accommodation expenses.

Details on the agenda, venue and other organisational aspects will soon be shared.

Register here to participate

Stay tuned for more updates!

Event Objectives

The PROPHET event aims to:

  • Present the PROPHET SRIA and Roadmap for personalised prevention
  • Foster collaboration between EU initiatives in the field
  • Facilitate knowledge exchange between researchers, policymakers, and industry stakeholders
  • Identify synergies between ongoing projects and initiatives
  • Explore future directions for personalised prevention research

Collaborating Initiatives

This joint event represents a unique opportunity to strengthen the European network of experts in personalised prevention and accelerate the translation of research findings into practical healthcare solutions.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen Vertical

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959